Increasing incidence of primary reverse and anatomic total shoulder arthroplasty in the United States.
Matthew J Best, Keith T Aziz, John H Wilckens...
https://pubmed.ncbi.nlm.nih.gov/32858194/Actively Recruiting
Led by North Texas Medical Research Institute, PLLC · Updated on 2025-08-15
20
Participants Needed
1
Research Sites
4 weeks
Total Duration
This research aims to find out if a treatment called cryoneurolysis can reduce pain after reverse total shoulder replacement surgery RTSA. Cryoneurolysis uses cold to temporarily block a nerve in the shoulder. The study compares those who receive this treatment before surgery to those who do not, to see if it lowers pain and reduces the need for opioid pain medications after RTSA. The trial is a randomized controlled pilot study involving two groups one receiving cryoneurolysis of the suprascapular nerve before RTSA and one not receiving this treatment. Cryoneurolysis is applied pre-operatively to study its effect on pain control and opioid use. The study will measure outcomes over a 90-day period following surgery. Participants will be monitored through various assessments including opioid usage measured by morphine milligram equivalents, pain scores using the Pain Assessment Documentation Tool, shoulder range of motion evaluations, and patient-reported outcomes via the American Shoulder and Elbow Surgeons shoulder score. The study involves pre-operative treatment, surgery, and follow-up assessments over three months to evaluate safety and effectiveness.
CONDITIONS
Cryoneurolysis of the Suprascapular Nerve for Perioperative Pain Control After Receiving a Reverse Total Shoulder Arthroplasty (RTSA)
J
Jeff Neumann, PA-C
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
North Texas Medical Research Institute, PLLC
Lead Sponsor
Pacira Pharmaceuticals, Inc
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Cryoneurolysis of Suprascapular Nerve | No Cryoneurolysis (Usual Care) |
|---|---|---|
| What it is | A procedure that applies controlled cold (cryoanalgesia) to the suprascapular nerve to decrease sensation and pain during and after reverse total shoulder arthroplasty. | Standard perioperative care for shoulder replacement surgery without any nerve cooling intervention. |
| Role in the trial | Investigational arm; assesses whether nerve cryoneurolysis can reduce postoperative pain and opioid use following RTSA. | Comparator arm; receives all usual perioperative care except for cryoneurolysis to provide a baseline for comparison. |
| Primary use | Aims to manage perioperative pain and reduce opioid consumption in patients having reverse total shoulder arthroplasty for degenerative joint disease. | Delivers perioperative pain management and care as typically provided for reverse total shoulder arthroplasty without special nerve-targeted procedures. |
| How it is given or performed | A cryoneurolysis probe is applied to the suprascapular nerve before surgery to produce cold-induced nerve signal disruption. | No nerve procedure is performed; standard medical and anesthesia protocols are followed for shoulder arthroplasty. |
| Evidence status | Evidence for suprascapular nerve cryoneurolysis in shoulder osteoarthritis is limited to case reports and general cryoanalgesia studies. Efficacy and opioid-sparing benefits are being studied in this trial. | Standard care for pain control after RTSA has established protocols, but may involve substantial opioid use and risk of persistent pain. No cryoneurolysis is expected to serve as the study comparator. |
| Important limitations | Current supporting evidence is mainly from case reports and theoretical literature; no large randomized controlled trials have established benefits or harms in this surgical application. Small pilot trial limits generalizability. | Standard care may leave some patients with significant pain or dependence on opioids; advancements in nonpharmacologic and nerve-targeted pain control are under investigation. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of surgery
Participants receive cryoneurolysis of the suprascapular nerve prior to their reverse total shoulder arthroplasty (RTSA) surgery or do not receive this intervention if assigned to the control group.
1 visit (in-person)
Duration - Up to discharge
Participants undergo reverse total shoulder arthroplasty surgery and receive immediate post-operative care.
1 visit (in-person)
Duration - 90 days
Participants are followed for 90 days after surgery to assess opioid usage, pain levels, shoulder range of motion, and patient-reported outcomes.
Approximately 6 post-operative visits
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Matthew J Best, Keith T Aziz, John H Wilckens...
https://pubmed.ncbi.nlm.nih.gov/32858194/Andrea M Trescot
https://pubmed.ncbi.nlm.nih.gov/16880882/Fraser MacRae, Eve Boissonnault, Mahdis Hashemi...
https://pubmed.ncbi.nlm.nih.gov/36968166/North Texas Medical Research Institute, PLLC
Lead Sponsor
Pacira Pharmaceuticals, Inc
Collaborating Sponsor